{"id":3093,"date":"2016-01-29T07:30:00","date_gmt":"2016-01-29T07:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xps-till-schweiz\/"},"modified":"2016-01-29T07:30:00","modified_gmt":"2016-01-29T07:30:00","slug":"xps-till-schweiz","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-till-schweiz\/","title":{"rendered":"XPS\u2122 till Schweiz"},"content":{"rendered":"
Universitetssjukhuset i Lausanne CHUV, Schweiz har beslutat att anskaffa Xvivo Perfusion System, XPS\u2122, vilket \u00e4r det f\u00f6rsta systemet som levereras till Schweiz. Leverans och installation av XPS\u2122 \u00e4r ber\u00e4knad att ske i mars 2016.<\/strong><\/div>\n<\/p>\n

XPS\u2122 \u00e4r marknadens enda system f\u00f6r Ex Vivo Lung Perfusion (EVLP) som \u00e4r godk\u00e4nd p\u00e5 alla viktiga marknader inklusive av FDA i USA. XPS\u2122 \u00e4r ett komplett system som ger anv\u00e4ndaren flexibilitet att genomf\u00f6ra utv\u00e4rdering av lungor inf\u00f6r transplantation genom ett standardiserat och f\u00f6renklat f\u00f6rfarande. EVLP med XPS\u2122 har gett goda kliniska resultat p\u00e5 ledande lungtransplantationskliniker i USA och Europa. I Europa kommer nu fem kliniker ha tillg\u00e5ng till XPS-systemet, varav en i Schweiz. <\/span><\/p>\n<\/p>\n

\u201dDet \u00e4r mycket gl\u00e4djande att kliniken i Lausanne, som \u00e4r en av de mest betydande i Schweiz, nu beslutat sig f\u00f6r att anv\u00e4nda EVLP med hj\u00e4lp av XPS\u2122-systemet\u201d. s\u00e4ger VD Magnus Nilsson, XVIVO Perfusion.<\/span><\/p>\n<\/p>\n

G\u00f6teborg 29 januari 2016
<\/span>XVIVO Perfusion AB (publ)<\/span><\/p>\n

\n

F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/p>\n

Christoffer Rosenblad, CFO, tel: 031-788 21 59 alternativt +1\u00a0720\u00a0616 2101, e-post: christoffer.rosenblad@xvivoperfusion.com<\/a>
F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/a><\/span><\/p>\n

Informationen l\u00e4mnades f\u00f6r publicering den 29 januari 2016 kl. 08:30.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Universitetssjukhuset i Lausanne CHUV, Schweiz har beslutat att anskaffa Xvivo Perfusion System, XPS\u2122, vilket \u00e4r det f\u00f6rsta systemet som levereras…<\/p>\n","protected":false},"template":"","class_list":["post-3093","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"\nXPS\u2122 till Schweiz - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-till-schweiz\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XPS\u2122 till Schweiz - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Universitetssjukhuset i Lausanne CHUV, Schweiz har beslutat att anskaffa Xvivo Perfusion System, XPS\u2122, vilket \u00e4r det f\u00f6rsta systemet som levereras...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-till-schweiz\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-till-schweiz\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-till-schweiz\\\/\",\"name\":\"XPS\u2122 till Schweiz - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2016-01-29T07:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-till-schweiz\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-till-schweiz\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-till-schweiz\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XPS\u2122 till Schweiz\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XPS\u2122 till Schweiz - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-till-schweiz\/","og_locale":"en_US","og_type":"article","og_title":"XPS\u2122 till Schweiz - XVIVO","og_description":"Universitetssjukhuset i Lausanne CHUV, Schweiz har beslutat att anskaffa Xvivo Perfusion System, XPS\u2122, vilket \u00e4r det f\u00f6rsta systemet som levereras...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-till-schweiz\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-till-schweiz\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-till-schweiz\/","name":"XPS\u2122 till Schweiz - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2016-01-29T07:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-till-schweiz\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-till-schweiz\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-till-schweiz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XPS\u2122 till Schweiz"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}